Sage Journals: Discover world-class research

Open access

Research article

First published 2025

Pembrolizumab versus pembrolizumab plus chemotherapy in patients with PDL1 ⩾50% advanced non-small-cell lung cancer,depending on tumor aggressiveness and clinical impact

Marine Lejeune, Eric Wasielewski, Vincent Leroy [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2019

Role of PDL1 as a prognostic marker in renal cell carcinoma: a prospective observational study in eastern India

Barun Kumar, Amlan Ghosh, Chhanda Datta [...]

Therapeutic Advances in Urology

Open access

Case report

First published 2020

Scalp Metastasis as the First Presentation of an Underlying Aggressive Pancreatic Cancer

Preethi Ramachandran, Lakshmi Boyapati, Gardith Joseph

Journal of Investigative Medicine High Impact Case Reports

Free access

Research article

First published 2024-5

PDL1 immunohistochemistry in canine neoplasms: Validation of commercial antibodies,standardization of evaluation,and scoring systems

Luisa Vera Muscatello, Francesca Gobbo, Giancarlo Avallone [...]

Veterinary Pathology

Open access

Review article

First published 2020

Advances in immunotherapy for colorectal cancer: a review

Gol Golshani, Yue Zhang

Therapeutic Advances in Gastroenterology

Free access

Review article

First published 2021-12

Higher Tumor Mutation Burden Was a Predictor for Better Outcome for NSCLC Patients Treated with PD-1 Antibodies: A Systematic Review and Meta-analysis

Yuhui Zheng, Meihong Yao, Yinghong Yang

Journal of Laboratory Automation

Open access

Research article

First published 2020

CSF1R and HCST: Novel Candidate Biomarkers Predicting the Response to Immunotherapy in Non-Small Cell Lung Cancer

Xiaoguang Qi, Chunyan Qi, Tao Wu [...]

Technology in Cancer Research & Treatment

Open access

Research article

First published 2024

Adipose mesenchymal stem cell conditioned medium and extract: A promising therapeutic option for regenerative breast cancer therapy

Faezeh Kazemi, Fatemeh Sadeghian, Ali Pirsadeghi [...]

Sage Open Medicine

Retricted access

Article commentary

First published 2019-1

Inferior outcomes in immunocompromised Merkel cell carcinoma patients: Can they be overcome by the use of PD1/PDL1 inhibitors?

Constantin A Dasanu, Michael Del Rosario, Ion Codreanu [...]

Journal of Oncology Pharmacy Practice

Retricted access

Review article

First published 2025-5

Bispecific antibodies (bsAbs) directed against PD-1/PD-L1 and CTLA-4;a mini review

Amirhossein Mardi, Leili Aghebati-Maleki

Human Antibodies

Search results